• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Supraglottic airway resuscitation likely more or just as effective as endotracheal intubation for out-of-hospital cardiac arrest

byDaniel Fisher
August 30, 2018
in Cardiology, Emergency, Neurology, Public Health, Pulmonology, Surgery
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. In an American, randomized controlled trial, supraglottic airway (SGA) resuscitation was associated with marginally better neurological outcomes and 72-hour survival compared to endotracheal intubation (ETI) for patients with out-of-hospital cardiac arrests (OHCA).

2. However, a similar English randomized controlled trial found no difference in favorable neurological outcomes 30 days after OHCA between SGA or ETI.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Though out-of-hospital cardiac arrests (OHCA) that require resuscitation are often fatal, timely emergency services are able increase survival. However, it is still unclear what the optimal airway management should be, especially between supraglottal airway (SGA) and endotracheal intubation (ETI) approaches. Two randomized controlled trials from the United States and England compared SGA and ETI for OHCA across multiple paramedic teams. In the American trial, SGA was associated with marginally better neurological outcomes and 72-hour survival compared to ETI while the British trial found no difference in favorable neurological outcomes after 30 days. Both trials noted quicker and fewer attempts at securing an airway with SGA compared to ETI.

Though previous population based studies have suggested ETI may be more effective than SGA for OHCA, these two well-designed and well-powered studies suggest that SGA is similar to and may be slightly more effective than ETI. In addition, the pragmatic design and randomization is a major strength compared to previous studies.

Click here to read the study in JAMA

RELATED REPORTS

Bougie-guided and stylet-guided intubation may have similar success rate in the intubation of trauma patients

2 Minute Medicine Rewind August 10, 2026

Resuscitative endovascular balloon occlusion of the aorta may not improve outcomes in adults with non-traumatic out-of-hospital cardiac arrest

Relevant Reading: Cardiovascular health through young adulthood and cognitive functioning in midlife

In-Depth [randomized controlled trial]: The Resuscitation Outcomes Consortium Pragmatic Airway Resuscitation Trial (PART) recruited 27 American EMS agencies and 3004 patients from December 2015 to November 2017. Paramedics were randomized 1:1 to a crossover design to administer laryngeal tube SGA or ETI resuscitation to patients 18 or older who suffered an OHCA. The 72-hour survival was greater in those who received SGA compared to ETI resuscitation (difference 2.9%; CI95 0.3 to 5.6%). SGA also led to improved return of circulation (adjusted difference 3.6%; CI95 0.3 to 6.8%), hospital survival (adjusted difference 2.7%; CI95 0.6 to 4.8%), and favorable neurological status at discharge (adjusted difference 2.1%; CI95 0.3% to 3.8%). ETI was associated with a greater chance of 3 or more airway insertion attempts (18.9 vs 4.5%) and more unsuccessful initial airway attempts than SGA (44.1 vs 11.8%).

The English AIRWAYS-2 trial recruited 4 EMS agencies covering 40% of the national population and recruited 9296 patients from June 2015 to August 2017. The favorable neurological outcomes were similar between SGA and ETI at 30-days after OHCA (risk difference −0.2%; CI95 −0.6 to 0.3). However, in the 7576 who received advanced airway management, SGA resulted in more favorable neurological outcomes than ETI (risk difference 1.4%; CI95 0.5 to 2.2%). SGA was more successful in achieving ventilation after two attempts than ETI (risk difference 2.1%; CI95 1.2 to 2.9%).

Image: CC/Wiki

©2018 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: cardiac arrestintubation
Previous Post

Clinical guidelines may lead to better prescribing practices

Next Post

Transcranial direct current stimulation linked to improved object naming post-stroke

RelatedReports

Postextubation administration of high-flow oxygen leads to reduced reintubation and respiratory failure
Emergency

Bougie-guided and stylet-guided intubation may have similar success rate in the intubation of trauma patients

August 11, 2026
Sleep duration, sleepiness, chronotype have variable associations with teen self-regulation
Weekly Rewinds

2 Minute Medicine Rewind August 10, 2026

August 10, 2026
Antiarrhythmic drugs have no survival benefit in shock-refractory out-of-hospital cardiac arrest
Cardiology

Resuscitative endovascular balloon occlusion of the aorta may not improve outcomes in adults with non-traumatic out-of-hospital cardiac arrest

May 14, 2026
Live attenuated vaccine less effective in recent influenza season
Weekly Rewinds

2 Minute Medicine Rewind May 11, 2026

May 11, 2026
Next Post
Rapid time to revascularization after ischemic stroke associated with improved functional outcomes

Transcranial direct current stimulation linked to improved object naming post-stroke

Adolescent mothers in protective care more likely to have their children placed in care

Prenatal and postnatal homelessness linked with poorer health outcomes

Attenuation values may help differentiate renal neoplasm from simple cyst on contrast-enhanced CT

Despite guidelines, use of CT for head trauma in children remains unchanged

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Cognitive behaviour therapy may be superior to bright light therapy for insomnia in women with breast cancer undergoing chemotherapy
  • Looksmaxxing raises body dysmorphia concerns among adolescent males
  • A healthy lifestyle may reduce risk of infection in patients with type 2 diabetes
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.

2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in